Nasdaq:US$13.27 (-0.21) | HKEX:HK$21.60 (+0.40) | AIM:£2.03 (-0.03)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 6 Jun 2012

Hutchison MediPharma Limited Announces Presentations of Sulfatinib and Fruquintinib Clinical Data at the 2012 ASCO Annual Meeting